Holen Sie sich die Stockscreener-App
1.705
48.32%
0.515
Handel nachbörslich:
1.52
-0.185
-10.85%
Artelo Biosciences Inc Aktie (ARTL) Neueste Nachrichten
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
ARTL Stock In Focus As Artelo Biosciences Taps AI For Drug Pipeline - StocksToTrade
Artelo Biosciences ARTL Jumps On AI Drug Discovery Pact - timothysykes.com
Which stocks are moving before the opening bell on Tuesday? - ChartMill
Wondering what's happening in today's after-hours session? - ChartMill
Why did ARTL stock skyrocket over 141% pre-market today? - MSN
Trending Stocks Today | Artelo Biosciences Soars 69.19% Post-Market - Moomoo
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Get insights into the top gainers and losers of Friday's after-hours session. - ChartMill
ARTL Stock Chart | ARTELO BIOSCIENCES INC (NASDAQ:ARTL) - ChartMill
[EFFECT] ARTELO BIOSCIENCES, INC. SEC Filing - Stock Titan
ARTL Stock Price, Quote & Chart | ARTELO BIOSCIENCES INC (NASDAQ:ARTL) - ChartMill
Avis Budget Group, Toyota Motor and other big stocks moving lower in Monday's pre-market session - MSN
Why LiveRamp Shares Are Trading Higher By Over 26%; Here Are 20 Stocks Moving Premarket - Sahm
ARTL (NASDAQ: ARTL) terminates $6.5M ATM; sold 50,858 shares for $451.5K - Stock Titan
Trending Industry Today: Artelo Biosciences Leads Losses In SOL Reserve Concept Stocks - Moomoo
Artelo Biosciences to terminate at-the-market offering agreement effective May 18, 2026SEC filing - marketscreener.com
Artelo Biosciences Ends ATM Offering, Shifts Financing Strategy - The Globe and Mail
Artelo Biosciences (NASDAQ: ARTL) ends $6.5M at-the-market stock program - Stock Titan
Artelo Biosciences | SCHEDULE 13G: Others - Moomoo
Armistice Capital (ARTL) reports 235,823 shares, 9.99% stake - Stock Titan
Artelo Biosciences (NASDAQ: ARTL) widens Q1 loss but boosts liquidity - Stock Titan
Artelo Biosciences Provides Business Update Outlining Upcoming Milestones and Reports 2026 First Quarter Financial Results - Yahoo Finance
Artelo Biosciences (ARTL) amends S-3; Exhibit 4.3 filed, fees noted - Stock Titan
Artelo Biosciences Stock Soars On Strong Preclinical Data In Par With Zoloft For Experimental Depression Drug - MSN
TradingKey - TradingKey
Artelo Biosciences Stock Soars 114% After Promising Depression Treatment Data - MSN
Why is ARTL stock soaring pre-market today? - MSN
Artelo Biosciences | S-3: Registration statement for specified transactions by certain issuers - Moomoo
Artelo Biosciences may offer securities up to $75 millionSEC filing - marketscreener.com
Artelo Biosciences (NASDAQ: ARTL) files $75M shelf, includes $69.29M unsold - Stock Titan
What's behind the rise in Artelo Biosciences stock? - MSN
Artelo Biosciences (ARTL) Partners with ScienceMachine for AI-Dr - GuruFocus
Artelo Biosciences Announces Strategic Collaboration with Artificial Intelligence (AI) Leader ScienceMachine Highlighting New Expansion Opportunities and Insights for FABP5 Inhibitor Development - The Manila Times
Artelo Biosciences Announces Strategic Collaboration with Artificial Intelligence Leader Sciencemachine Highlighting New Expansion Opportunities and Insights for FABP5 Inhibitor Development - marketscreener.com
ARTL - Finviz
Artelo Biosciences stock soars after withdrawing SEC filing - MSN
Artelo (ARTL) Stock Fundamentals | Q4 2025: EPS Exceeds ExpectationsRetail Trader Ideas - Cổng thông tin điện tử tỉnh Tây Ninh
1.49%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):